Despite being a preventable and curable disease, tuberculosis (TB) remains a leading cause of death, causing
In addition, the WHO estimates that some
Efforts to stem the spread of TB have been further hindered by the coronavirus pandemic, as health and socioeconomic systems worldwide have come under intense strain. The impact of the pandemic on TB communities has triggered governments and non-governmental organisations to rethink TB diagnostics and patient care.
A reliable and accurate diagnosis for TB not only lowers the risk of further transmission, but also reduces delays in treatment and additional healthcare and socioeconomic system burdens. Roche is participating in several initiatives to help eliminate TB worldwide.
In 2019, we expanded our
Since July 2021, our tests have been part of the expanded WHO guidelines to support TB diagnostics in resource-limited countries. By expanding the number of molecular tests available to national TB programs, patients in high-burden countries have improved access to diagnostics. In addition, LMICs now have diverse options for TB diagnostics that enable multi-partner approaches to ensure the optimal diagnostic system is placed in a given environment that will best serve patients. All this will support clinicians in properly diagnosing infections, accelerate treatment and reduce the spread of infection.
Up to 50% of cases of some infectious diseases originate in the workplace. Launched at the World Economic Forum in January 2020, EWTB is a coalition of companies and key organisations active in the fight against TB. It brings together some of the world’s leading practitioners of workplace health programming with leading technical agencies and non-governmental organisations to build policies and programmes for healthier, disease-safe workplaces. Roche joined the EWTB coalition in 2022 and is aiming to increase awareness of tuberculosis within key audiences to ensure that workers with TB are not discriminated against.
The coronavirus (COVID-19) pandemic has caused enormous health, social and economic impacts in 2020 and
A unique characteristic of Roche’s diagnostic tools is that a single instrument can be used to detect multiple diseases. Our